Mariëlle Eerdekens, MD, MBA
- 4Articles
- 10.1KReads1
- 2003–2008Active
- 20Collaborators
1 Read counts for articles published before 2020 may include some non-human traffic.
About
Mariëlle Eerdekens, MD, MBA, has published extensively on the treatment of schizophrenia and schizoaffective disorders. Her work focuses on the efficacy, safety, and tolerability of antipsychotic medications, including oral paliperidone extended-release tablets and long-acting injectable risperidone. She has contributed to studies examining treatment outcomes, health-related quality of life, and medication switching strategies in patients with schizophrenia. Her research was published between 2003 and 2008 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
